Avara Management Ltd, 10% Owner, Director at Royalty Pharma plc (RPRX), sold 422,760 shares at $41.17 ($17.4M) on 2022-09-22, disclosed to the SEC on 2022-09-26.
Open-market sale of $17.4M RPRX by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.17 | 211,380 | $8.7M | 50.0% |
| 2 | $41.17 | 211,380 | $8.7M | 50.0% |
| Total | $41.17 avg | 422,760 | $17.4M | 100% |
| Filing → |
| RPRX | SELL | 2022-12-07 | $7.3M | — | Filing → |
| RPRX | SELL | 2022-09-30 | $2.7M | — | Filing → |
| RPRX | SELL | 2022-09-09 | $42.7M | — | Filing → |